Patient Results for Moderate to Severe Plaque PsO | TREMFYA® (guselkumab) HCP
  1. Efficacy in PsO
  2. Before-and-after

SEARCH THE TREMFYA® SITE

IN MODERATE TO SEVERE PLAQUE PsO

See clearer skin
with TREMFYA®*

left

right

PASI=32.8

PASI=8.4

PASI=2.8

abcd

Week 0

Week 16

Week 48

Age:
36

BMI:
31.1 kg/m2

Baseline BSA
involvement:
54%

Psoriasis duration:
12 years

Previous therapies:
topicals, biologics

*Individual results may vary. Plaque psoriasis photos are of a real patient from VOYAGE 2 who received TREMFYA® 100 mg at Week 0 and 4, then q8w thereafter through Week 48. Other areas affected (not shown), yielded similar results to those depicted here. Clinical photos shown here are from Week 0, Week 16, and Week 48. Digital effects were used to transition between timepoints. Photos are for illustrative purposes only and are used with permission from Janssen Biotech Inc.

BMI=body mass index; BSA=body surface area.

Reference: 1. Data on file. Janssen Biotech, Inc.

abcd

Week 0

Week 4

Week 16

Patient photos represent results captured at baseline (Week 0), Week 4, and Week 16 outside of clinical trials. Digital effects were used to transition between these timepoints.
*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

abcd

Week 0

Week 16

Patient photos represent results captured at baseline (Week 0) and Week 16 outside of clinical trials. Digital effects were used to transition between these timepoints.
*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

patient_4_legs_before_mobile

patient_4_legs_after_mobile

abcd

Week 0

Week 16

Patient photos represent results captured at baseline (Week 0) and Week 16 outside of clinical trials. Digital effects were used to transition between these timepoints.
*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

patient_5_ear_before_mobile

patient_5_ear_after_mobile

abcd

Week 0

Week 16

Patient photos represent results captured at baseline (Week 0) and Week 16 outside of clinical trials. Digital effects were used to transition between these timepoints.
*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Back to Top